Evidence map›Paper›PMID 25299047›Full record

ArticlePloS one2014

Interaction mortality: senescence may have evolved because it increases lifespan.

Maarten J Wensink, Tomasz F Wrycza, Annette Baudisch

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. The Danaid Theory of Aging.Frontiers in cell and developmental biology · 2021
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maarten J WensinkMax Planck Research Group 'Modeling the Evolution of Aging, Max Planck Institute for Demographic Research, Rostock, Germany; Leyden Academy on Vitality and Ageing, Leiden, The Netherlands.
Tomasz F WryczaMax Planck Research Group 'Modeling the Evolution of Aging, Max Planck Institute for Demographic Research, Rostock, Germany.
Annette BaudischMax Planck Research Group 'Modeling the Evolution of Aging, Max Planck Institute for Demographic Research, Rostock, Germany; Max-Planck Odense Center on the Biodemography of Aging, University of Southern Denmark, Odense M, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given an extrinsic challenge, an organism may die or not depending on how the threat interacts with the organism's physiological state. To date, such interaction mortality has been only a minor factor in theoretical modeling of senescence. We describe a model of interaction mortality that does not involve specific functions, making only modest assumptions. Our model distinguishes explicitly between the physiological state of an organism and potential extrinsic, age-independent threats. The resulting mortality may change with age, depending on whether the organism's state changes with age. We find that depending on the physiological constraints, any outcome, be it 'no senescence' or 'high rate of senescence', can be found in any environment; that the highest optimal rate of senescence emerges for an intermediate physiological constraint, i.e. intermediate strength of trade-off; and that the optimal rate of senescence as a function of the environment is driven by the way the environment changes the effect of the organism's state on mortality. We conclude that knowledge about the environment, physiology and their interaction is necessary before reasonable predictions about the evolution of senescence can be made.

Indexed as

DeathModels, StatisticalBiological EvolutionEnvironmentHumansLongevity

Identifiers

PMID25299047
PMCPMC4192302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.